M. Huisman

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M.v. Huisman, Menno Volkert Huisman, M. V. Huisman, Menno Huisman, Menno V. Huisman, Menno V Huisman
Publication record
136 papers · 7,231 citations · H-index 41

PAPERS

Geriatric characteristics and outcomes of older patients diagnosed with acute pulmonary embolism in the emergency department
20260 citationsauthor #9
Safety and efficiency of D-dimer testing in combination with clinical decision rules to exclude pulmonary embolism in patients with cancer: individual patient data meta-analysis.
20250 citationsauthor #8
Assessment of clinical probability scores for pulmonary embolism diagnosis during pregnancy and postpartum in women with a history of venous thromboembolism: a Highlow ancillary study
20250 citationsauthor #108
Corrigendum to ‘Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway’
20250 citationsauthor #4
YEARS clinical decision rule for diagnosing pulmonary embolism: a prospective diagnostic cohort follow-up study in primary care
20253 citationsauthor #6
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
202552 citationsauthor #16
Key elements of follow-up care after acute pulmonary embolism focusing on long-term sequelae: a Delphi study among European experts
20250 citationsauthor #34
Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway.
20250 citationsauthor #4
Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism.
20253 citationsauthor #8
Higher blood pressure variability during hospitalisation is associated with lower cerebral white matter integrity in COVID-19 patients
20250 citationsauthor #9
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism.
20250 citationsauthor #11
Intermittent compression devices as antithrombotic strategy in neurosurgical interventions: a prospective randomised controlled trial (TIPOTEE).
20250 citationsauthor #3
Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one-size-fits-all’ approach in patients undergoing Total hIp or total kNee replaCemenT – a national, multicentre, randomised, multiarm, open-label trial
20250 citationsauthor #6
Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study.
20251 citationsauthor #17
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysis
20251 citationsauthor #10
Cardiopulmonary exercise testing in dyspnoeic persons with a recent acute pulmonary embolism
20251 citationsauthor #7
Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation
20242 citationsauthor #7
Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative
20248 citationsauthor #7
Care Pathway of Venous Thromboembolism (VTE)
20242 citationsauthor #4
First Experiences of Patients and Healthcare Professionals with Routine Use of Patient-Reported Outcome Measures for Venous Thromboembolism
20240 citationsauthor #5
The History of Diagnosing Venous Thromboembolism
20245 citationsauthor #2
Use of Magnetic Resonance Direct Thrombus Imaging for the Diagnostic Management of Suspected Thrombosis in Routine Clinical Practice
20241 citationsauthor #8
[Coumarin or DOAC in frail elderly patients with atrial fibrillation?]
20240 citationsauthor #4
Prevalence and 3-month follow-up of cerebrovascular MRI markers in hospitalized COVID-19 patients: the CORONIS study
20241 citationsauthor #12
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial
20244 citationsauthor #30
Optimisation of detecting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism survivors: the InShape IV study
20244 citationsauthor #8
Increase in venous thromboembolism in SARS‐CoV‐2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi
20242 citationsauthor #6
Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry
20249 citationsauthor #4
Risks of major bleeding and venous thromboembolism in patients undergoing total hip or total knee arthroplasty using therapeutic dosages of DOACs
20242 citationsauthor #4
Outpatient management of cancer-related pulmonary embolism: a post-hoc analysis of the HOME-PE trial
20231 citationsauthor #30
Cost-Effectiveness of Performing Reference Ultrasonography in Patients with Deep Vein Thrombosis
20233 citationsauthor #13
Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
20235 citationsauthor #6
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry.
202313 citationsauthor #8
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
20237 citationsauthor #13
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
202311 citationsauthor #4
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer
20234 citationsauthor #6
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
202335 citationsauthor #10
Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA‐AF
202316 citationsauthor #6
Why the grass isn't always greener on the machine learning side.
20230 citationsauthor #2
Treatment Patterns of Cancer-associated Thrombosis in the Netherlands: The Four Cities Study
20230 citationsauthor #8
Oral anticoagulant use and outcomes in Asian patients with atrial fibrillation in the GLORIA-AF Registry
20230 citationsauthor #10
Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
2023127 citationsauthor #8
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study.
20234 citationsauthor #7
Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
20231 citationsauthor #6
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
20220 citationsauthor #1
Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
20217 citationsauthor #7
Abstract 13772: Anticoagulation Guideline Adherence in 4,500 Patients With Newly Diagnosed Atrial Fibrillation: Insights From the Prospective DUTCH-AF Registry
20211 citationsauthor #9
Pulmonary infarction in acute pulmonary embolism.
202182 citationsauthor #6
Association between cardiovascular risk factors and intracranial hemorrhage in patients with acute leukemia
20214 citationsauthor #4
Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry.
20200 citationsauthor #2
Lack of diagnostic utility of the ECG-derived ventricular gradient in patients with suspected acute pulmonary embolism.
20205 citationsauthor #3
Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
20204 citationsauthor #8
Diagnosis of suspected recurrent ipsilateral deep vein thrombosis with magnetic resonance direct thrombus imaging.
202050 citationsauthor #10
Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
20201 citationsauthor #7
More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism
20208 citationsauthor #7
Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients
202062 citationsauthor #16
Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group
202058 citationsauthor #22
When to withhold oral anticoagulation in atrial ﬁ brillation – an overview of frequent clinical discussion topics
20191 citationsauthor #3
Elastic compression stockings one year after DVT diagnosis: Who might discontinue?
20197 citationsauthor #18
Risk of Recurrent Venous Thromboembolism and Major Haemorrhage in Cancer-Associated Incidental Pulmonary Embolism amongst Treated and Untreated Patients - a pooled analysis of 926 patients Tom
20190 citationsauthor #27
Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
201916 citationsauthor #10
Consequences of pre-injury utilization of direct oral anticoagulants (DOACs) in patients with traumatic brain injury (TBI): a systematic review and meta-analysis.
201927 citationsauthor #5
Predicting Post-Thrombotic Syndrome with Ultrasonographic Follow-Up after Deep Vein Thrombosis: A Systematic Review and Meta-Analysis
201847 citationsauthor #5
Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
201836 citationsauthor #5
Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints
20184 citationsauthor #5
Sex‐specific performance of pre‐imaging diagnostic algorithms for pulmonary embolism
201811 citationsauthor #8
Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism
20188 citationsauthor #4
THE ORIGINAL AND SIMPLIFIED WELLS RULES AND AGE-ADJUSTED D-DIMER TESTING TO RULE OUT PULMONARY EMBOLISM: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
20171 citationsauthor #3
Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.
201715 citationsauthor #9
Is stand‐alone D‐dimer testing safe to rule out acute pulmonary embolism?
201714 citationsauthor #5
Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH
201729 citationsauthor #6
No added value of the age‐adjusted D‐dimer cut‐off to the YEARS algorithm in patients with suspected pulmonary embolism
201710 citationsauthor #14
Continuation of low‐molecular‐weight heparin treatment for cancer‐related venous thromboembolism: a prospective cohort study in daily clinical practice
201756 citationsauthor #8
Current standings in diagnostic management of acute venous thromboembolism: Still rough around the edges.
201622 citationsauthor #3
Current and future perspectives in imaging of venous thromboembolism
201649 citationsauthor #3
Recent developments in the diagnosis and treatment of pulmonary embolism
201626 citationsauthor #4
Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
2016148 citationsauthor #7
Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
2016417 citationsauthor #4
Coronary or thoracic artery calcium score in provoked and unprovoked pulmonary embolism: a case‐control study
20169 citationsauthor #3
Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial.
2016109 citationsauthor #20
Corrigendum to: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.
201533 citationsauthor #8
Can and should carotid ultrasound be used in cardiovascular risk assessment?: the internist's perspective.
201510 citationsauthor #2
Letter by Klok et al Regarding Article, "18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus".
201520 citationsauthor #3
A simple decision rule including D‐dimer to reduce the need for computed tomography scanning in patients with suspected pulmonary embolism
201544 citationsauthor #7
Misinterpretation of the Comparative Safety of Testosterone Dosage Forms.
20150 citationsauthor #3
External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
201555 citationsauthor #6
The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS)
20141,700 citationsauthor #2
Right ventricular function and thrombus load in patients with pulmonary embolism and diagnostic delay
20146 citationsauthor #6
The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.
2014360 citationsauthor #5
[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism].
2014635 citationsauthor #8
Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography–pulmonary angiography
201448 citationsauthor #12
Validation of the Ottawa prognostic score for the prediction of recurrent venous thromboembolism in patients with cancer‐associated thrombosis
201352 citationsauthor #3
Physicians’ management approach to an incidental pulmonary embolism: an international survey
201339 citationsauthor #7
Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast‐enhanced computed tomography imaging in cancer patients
201326 citationsauthor #6
Diagnostic management of acute deep vein thrombosis and pulmonary embolism
2013169 citationsauthor #1
Adjustments in the diagnostic work-up , treatment and prognosis of pulmonary embolism
20130 citationsauthor #11
Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function
201377 citationsauthor #14
Performance of four clinical decision rules in patients with malignancy and suspected pulmonary embolism
20128 citationsauthor #4
Magnetic resonance imaging for diagnosis of acute pulmonary embolism: not yet a suitable alternative to CT‐PA
201216 citationsauthor #1
The diagnostic management of acute venous thromboembolism during pregnancy: recent advancements and unresolved issues.
201121 citationsauthor #2

TIMELINE

1989 33 citations

1990 48 citations

1991 34 citations

1997 8 citations

1999 233 citations

2000 32 citations

2001 89 citations

2003 23 citations

2005 66 citations

2006 132 citations

2007 595 citations

2008 7 citations

2009 412 citations

2010 411 citations

2011 149 citations

2012 24 citations

2013 363 citations

2014 2,749 citations

2015 162 citations

2016 780 citations

2017 125 citations

2018 106 citations

2019 51 citations

2020 188 citations

2021 94 citations

2022 0 citations

2023 227 citations

2024 40 citations

2025 61 citations

2026 0 citations

Unknown 0 citations

M. Huisman

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT